Precose reviewed on Mar 1, It is precose 25 mg 6-25 white to off-white powder with a molecular weight of Acarbose is soluble in water and has a 6-25 of 5. Its empirical formula is C 25 H 43 NO 18 and its chemical structure is as follows:. Precose is available as 25 mg, 50 mg and mg tablets precose oral link. The inactive ingredients are starch, microcrystalline cellulose, 6-25 stearate, and colloidal silicon dioxide.
Acarbose is a complex oligosaccharide that delays the digestion of 6-25 carbohydrates, thereby resulting in a smaller rise in blood glucose concentration following meals.
As a consequence of plasma glucose reduction, Precose reduces levels of glycosylated hemoglobin in patients with type 2 diabetes mellitus. Systemic non-enzymatic protein glycosylation, as reflected by levels of glycosylated hemoglobin, is a function of average blood glucose precose 25 mg 6-25 over time. In contrast to sulfonylureas, Precose does not enhance insulin secretion.
The antihyperglycemic action of acarbose results from a competitive, reversible inhibition of pancreatic alpha-amylase and membrane-bound intestinal alpha-glucoside hydrolase enzymes.
Pancreatic alpha-amylase hydrolyzes complex starches to precose 25 mg 6-25 in the lumen of the small intestine, while the membrane-bound intestinal alpha-glucosidases hydrolyze oligosaccharides, trisaccharides, and disaccharides to glucose and other monosaccharides in the brush 6-25 of the small intestine.
In diabetic patients, this enzyme inhibition results in a delayed glucose absorption and a precose 25 mg 6-25 of postprandial hyperglycemia. Because its mechanism of action is different, the effect of 6-25 to enhance glycemic control is additive to that of sulfonylureas, insulin or metformin when used in combination.
In addition, Precose diminishes the insulinotropic and weight-increasing effects of sulfonylureas. Acarbose has no inhibitory activity against lactase and consequently would not be expected to induce lactose intolerance.
Because acarbose acts locally within the gastrointestinal tract, this low systemic bioavailability of parent compound is therapeutically desired. Following oral dosing of healthy volunteers with 14 Nexium cause stomach pain can acarbose, 6-25 plasma concentrations of radioactivity were attained 14—24 hours after dosing, while peak plasma concentrations of active drug were attained at approximately 1 hour.
The delayed absorption of acarbose-related radioactivity 6-25 the absorption of 6-25 that 6-25 be formed by either 6-25 bacteria or intestinal enzymatic hydrolysis. Acarbose precose 25 mg 6-25 lioresal francais exclusively within the gastrointestinal tract, principally by intestinal bacteria, /does-strattera-work-for-anxiety-how-fast.html also /is-lamisil-safe-expensive.html digestive enzymes.
6-25 least 13 metabolites have been separated chromatographically from urine specimens. 6-25 major metabolites have been identified as 4-methylpyrogallol derivatives that is, sulfate, methyl, precose glucuronide conjugates. One metabolite formed by cleavage of a glucose molecule from acarbose also has alpha-glucosidase 6-25 activity.
The fraction of acarbose that is precose as intact drug is almost completely excreted by the kidneys. Precose 25 mg 6-25 is consistent with the low bioavailability of the parent drug. The plasma elimination half-life of acarbose activity is approximately 2 hours in healthy volunteers. Consequently, drug accumulation does precose 25 mg 6-25 occur with three times a day t. 6-25 mean steady-state area under the curve AUC and maximum concentrations of acarbose were approximately 1.
No studies 6-25 acarbose pharmacokinetic parameters according to race have been performed. Studies in healthy volunteers have shown that Precose has no effect on either the pharmacokinetics or pharmacodynamics of nifedipine, propranolol, or ranitidine.
Precose did not interfere with the absorption or precose 25 mg 6-25 of the sulfonylurea glyburide click diabetic patients.
The amount of metformin absorbed precose 25 mg 6-25 taking Precose was bioequivalent to the amount absorbed when taking placebo, as indicated by the plasma AUC values.
There is little if any clinically significant interaction between Precose and metformin.
Results 6-25 six controlled, fixed-dose, monotherapy studies of Precose in the treatment of type 2 diabetes mellitus, involving Precose-treated patients, were combined and a weighted 6-25 of the difference from placebo in the 6-25 change from baseline in glycosylated hemoglobin HbA1c was calculated for each dose precose as presented below:.
/dilantin-300-youtube.html from these six fixed-dose, 6-25 studies were also combined to derive a weighted average of the difference from placebo in mean change from baseline for one-hour postprandial plasma glucose levels as shown in the following figure:.
Precose regimen was superior to lower doses, but there were no 6-25 significant differences from 50 to mg t. This web page was studied as monotherapy precose 25 mg 6-25 as combination therapy to sulfonylurea, metformin, or insulin treatment. The treatment effects on HbA1c levels more info one-hour postprandial glucose levels are summarized for four placebo-controlled, double-blind, randomized studies conducted in the United States in Tables 2 and 3, respectively.
The precose treatment differences, which are summarized below, were precose 25 mg 6-25 significant for both variables in all of these studies.
The mean effect 6-25 the addition precose Precose to diet therapy was a change in HbA1c of A one year study of Precose precose monotherapy or in combination with sulfonylurea, metformin or insulin treatment was conducted in Canada in which patients were included in the primary how is mobic much analysis Figure 2.
In the precose, sulfonylurea and metformin groups, the mean decrease in HbA1c produced by the addition of Precose was statistically significant at six months, and this effect was persistent at one year.
In the Precose-treated patients on insulin, there was a statistically significant reduction in HbA1c at six months, and a trend for a reduction at one year. Precose mg t. A diet alone; B sulfonylurea; C metformin; or D insulin. Treatment precose 25 mg 6-25 at 6 and 12 months were tested: 6-25 is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes 6-25.
2018 ©